Dottikon ES Holding Future Growth

Dottikon ES Holding is forecast to grow revenue at 14.5% per annum. EPS is expected to grow by 10.8% per annum.

n/a

Earnings growth rate

10.8%

EPS growth rate

Pharmaceuticals earnings growth	19.6%
Revenue growth rate	14.5%
Future return on equity	8.6%
Analyst coverage	Low
Last updated	15 Nov 2024

No updates

Earnings and Revenue Growth Forecasts

LSE:0ACK - Analysts future estimates and past financials data (CHF Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
3/31/2026	447	N/A	N/A	N/A	1
3/31/2025	395	N/A	N/A	N/A	1
3/31/2024	333	81	-57	103	N/A
12/31/2023	339	83	-62	96	N/A
3/31/2023	326	88	-47	90	N/A
12/31/2022	302	81	-40	82	N/A
9/30/2022	284	74	-34	74	N/A
6/30/2022	268	67	-39	55	N/A
3/31/2022	252	59	-43	36	N/A
12/31/2021	240	57	-35	31	N/A
9/30/2021	229	55	-28	26	N/A
6/30/2021	224	54	-10	43	N/A
3/31/2021	219	52	8	60	N/A
12/31/2020	204	46	18	66	N/A
9/30/2020	189	39	28	72	N/A
6/30/2020	182	36	14	58	N/A
3/31/2020	175	33	-1	44	N/A
12/31/2019	172	31	-9	38	N/A
9/30/2019	169	30	-18	31	N/A
6/30/2019	158	23	-14	35	N/A
3/31/2019	148	16	-11	38	N/A
12/31/2018	147	17	-14	32	N/A
9/30/2018	145	18	-18	25	N/A
6/30/2018	153	22	-7	32	N/A
3/31/2018	161	26	4	39	N/A
12/31/2017	159	24	N/A	40	N/A
9/30/2017	157	22	N/A	40	N/A
6/30/2017	156	22	N/A	48	N/A
3/31/2017	155	22	N/A	57	N/A
12/31/2016	151	22	N/A	58	N/A
9/30/2016	148	23	N/A	59	N/A
6/30/2016	136	19	N/A	32	N/A
3/31/2016	123	14	N/A	6	N/A
12/31/2015	113	10	N/A	1	N/A
9/30/2015	102	5	N/A	-3	N/A
6/30/2015	100	3	N/A	4	N/A
3/31/2015	98	1	N/A	11	N/A
12/31/2014	95	0	N/A	15	N/A
9/30/2014	91	-1	N/A	18	N/A
6/30/2014	91	-2	N/A	13	N/A
3/31/2014	92	-3	N/A	8	N/A
12/31/2013	89	-5	N/A	4	N/A

Earnings vs Savings Rate: Insufficient data to determine if 0ACK's forecast earnings growth is above the savings rate (2.1%).

Earnings vs Market: Insufficient data to determine if 0ACK's earnings are forecast to grow faster than the UK market

High Growth Earnings: Insufficient data to determine if 0ACK's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 0ACK's revenue (14.5% per year) is forecast to grow faster than the UK market (3.6% per year).

High Growth Revenue: 0ACK's revenue (14.5% per year) is forecast to grow slower than 20% per year.

Future ROE: 0ACK's Return on Equity is forecast to be low in 3 years time (8.6%).